ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 203 filers reported holding ZAI LAB LTD in Q4 2021. The put-call ratio across all filers is 1.80 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $117,737,000 | -40.3% | 1,873,311 | +0.0% | 0.22% | -41.8% |
| Q3 2021 | $197,376,000 | -45.0% | 1,872,818 | -7.6% | 0.38% | -43.8% |
| Q2 2021 | $358,903,000 | +35.7% | 2,027,815 | +2.3% | 0.67% | +30.4% |
| Q1 2021 | $264,480,000 | -1.8% | 1,982,166 | -0.4% | 0.51% | -6.9% |
| Q4 2020 | $269,443,000 | +62.7% | 1,990,860 | -0.0% | 0.55% | +42.0% |
| Q3 2020 | $165,639,000 | +1.4% | 1,991,575 | +0.1% | 0.39% | -4.0% |
| Q2 2020 | $163,356,000 | +59.5% | 1,988,989 | 0.0% | 0.40% | +34.2% |
| Q1 2020 | $102,393,000 | +51.0% | 1,988,989 | +22.0% | 0.30% | +99.3% |
| Q4 2019 | $67,817,000 | +40.8% | 1,630,600 | +9.5% | 0.15% | +28.0% |
| Q3 2019 | $48,169,000 | -0.3% | 1,489,000 | +7.4% | 0.12% | +0.9% |
| Q2 2019 | $48,333,000 | +253.2% | 1,386,100 | +198.9% | 0.12% | +244.1% |
| Q1 2019 | $13,685,000 | +42.0% | 463,755 | +11.7% | 0.03% | +30.8% |
| Q4 2018 | $9,636,000 | +97.9% | 415,000 | +66.0% | 0.03% | +136.4% |
| Q3 2018 | $4,870,000 | – | 250,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Genesis Investment Management, LLP | 1,032,166 | $25,091,955 | 3.50% |
| XY Capital Ltd | 139,743 | $3,397,152 | 1.95% |
| Paradigm Biocapital Advisors LP | 1,142,383 | $27,771,331 | 1.88% |
| Privium Fund Management B.V. | 240,683 | $5,851,004 | 1.74% |
| Segantii Capital Management Ltd | 1,788,999 | $43,262,801 | 1.52% |
| Vivo Capital, LLC | 454,606 | $11,051,472 | 1.21% |
| BRILLIANCE ASSET MANAGEMENT LTD | 157,085 | $3,818,736 | 0.96% |
| Capricorn Fund Managers Ltd | 100,967 | $2,454,508 | 0.85% |
| Rock Springs Capital Management LP | 1,237,023 | $30,072,029 | 0.81% |
| Long Corridor Asset Management Ltd | 31,000 | $753,610 | 0.66% |